HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.
Tuesday, 31 March 2015
EUnetHTA joint rapid assessment on sorafenib as a treatment for thyroid carcinoma…
…has been published. But will it be used? For an answer to this question, see our previous post.
